Valuation (16%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.16 | -23.05 |
PEG Ratio (TTM) | 0.19 | 15.47 |
P/S Ratio (TTM) | 110.51 | 49.46 |
P/B Ratio (TTM) | -4.02 | 18.87 |
P/FCF Ratio (TTM) | -5.05 | -3.27 |
Price to 5YR AVG Earnings Ratio | -3.07 | -3.55 |
Price to 5YR AVG FCF Ratio | -9.64 | -9.37 |
Profitability (50%) |
Company | Industry |
---|---|---|
ROA (TTM) | -93.03% | -5.14% |
ROE (TTM) | 251.33% | 16.69% |
Net Profit Margin (TTM) | -2,995.68% | -1,583.93% |
ROIC 5YR AVG | 140.09% | 15.15% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -21.35% | -1,833.46% | -1,102.36% |
Revenue | 115.85% | N/A | N/A |
Net Income | -26.02% | -5,386.37% | -3,240.02% |
Cash Flow | -35.26% | -1,224.35% | -733.11% |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.48 | 6.13 |
Quick Ratio (TTM) | 6.44 | 5.85 |
D/E Ratio (TTM) | -2.17 | -15.81 |
Interest Coverage (TTM) | -6.68 | -1.57 |
Piotroski F-Score | 4 | 5 |
Altman Z-Score | N/A | 14.12 |
LTL to 5YR AVG FCF | -1.22 | 0.17 |
Shares Outstanding Growth 5YR AVG | 54.17% | 123.44% |